KEY FINDINGS
The China neurovascular devices / interventional neurology market is estimated to record a CAGR of 5.22% during the forecast period, 2021-2026. The surging elderly population and the increasing R&D activities in neuro therapies are the key factors driving the market growth.
MARKET INSIGHTS
The increasing aging population contributes to the prevalence of dementia in the rural and semi-urban provinces of the country. As per the World Bank data, the country is the largest globally with regard to population, influencing Alzheimer’s prevalence.
Further, the country faces the greatest challenge of stroke. Approximately 2 million cases are registered every year. The growing incidences of stroke have led to increased awareness. The government is involved in spreading the knowledge and providing enhanced treatment, healthcare coverage, and medical technology. Moreover, China is investing more in the prevention and treatment of non-communicable diseases. Furthermore, the government has standardized the advanced techniques for stroke prevention and treatment for physicians across the country. Such factors are set to propel market growth in China.
COMPETITIVE INSIGHTS
Some of the leading companies in the market include Kaneka Corporation, Microport Scientific Corporation, Terumo Medical Corporation (Microvention Inc), B Braun Melsungen AG, Medtronic Inc, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
'
TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. COUNTRY SNAPSHOT
2.3. COUNTRY ANALYSIS
2.4. KEY GROWTH ENABLERS
2.5. KEY CHALLENGES
3. KEY ANALYTICS
3.1. IMPACT OF COVID-19 ON NEUROVASCULAR DEVICES MARKET
3.2. KEY MARKET TRENDS
3.3. PORTER’S FIVE FORCES ANALYSIS
3.3.1. BUYERS POWER
3.3.2. SUPPLIERS POWER
3.3.3. SUBSTITUTION
3.3.4. NEW ENTRY
3.3.5. INDUSTRY RIVALRY
3.4. OPPORTUNITY MATRIX
3.5. VENDOR LANDSCAPE
4. MARKET BY PRODUCT
4.1. EMBOLIZATION DEVICES
4.2. ACCESSORY DEVICES
4.3. REVASCULARIZATION DEVICES
4.4. THROMBECTOMY DEVICES
4.5. EMBOLIC PROTECTION DEVICES
5. MARKET BY APPLICATION
5.1. ANEURYSM
5.2. ISCHEMIC STROKE
5.3. STENOSIS
5.4. ARTERIOVENOUS MALFORMATION (AVM)
5.5. OTHER APPLICATIONS
6. COMPETITIVE LANDSCAPE
6.1. KEY STRATEGIC DEVELOPMENTS
6.1.1. MERGERS & ACQUISITIONS
6.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
6.1.3. PARTNERSHIPS & AGREEMENTS
6.1.4. BUSINESS EXPANSIONS, ANNOUNCEMENTS & DIVESTITURES
6.2. COMPANY PROFILES
6.2.1. B BRAUN MELSUNGEN AG
6.2.2. KANEKA CORPORATION
6.2.3. MEDTRONIC INC
6.2.4. MICROPORT SCIENTIFIC CORPORATION
6.2.5. TERUMO MEDICAL CORPORATION (MICROVENTION INC)
1. B BRAUN MELSUNGEN AG
2. KANEKA CORPORATION
3. MEDTRONIC INC
4. MICROPORT SCIENTIFIC CORPORATION
5. TERUMO MEDICAL CORPORATION (MICROVENTION INC)
